Clinical Trial Update: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of ensifentrine in COPD has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ensifentrine (ensifentrine)

Snippet

Sponsor: Verona Pharma plc | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-07-24